marijuana stocks news

Cara Therapeutics to Webcast Presentation at 17th Annual BIO CEO & Investor Conference

SHELTON, Conn., Feb. 2, 2015 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015, at 8:30 a.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200
Jesse@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB Scientific Advisory Board Chairman Publishes Review Article

PharmaCyte Biotech’s Scientific Advisory Board Chairman Publishes Review Article on the Pathology…

Trulieve Cannabis Corp. (TCNNF) Announces Appointment of Ryan Blust as Interim Chief Financial Officer

Trulieve Announces Appointment of Ryan Blust as Interim Chief Financial Officer Trulieve…

$NVLX Execs to Attend 2015 Gastrointestinal Cancers Symposium

Nuvilex to Attend 2015 Gastrointestinal Cancers Symposium in San Francisco, January 15-17,…

$CBIS Pleased with CNN Monitoring of The Outcome of State By State Voting for Medical Marijuana Legalization

Cannabis Science Enthused With CNN Monitoring The Outcome Of The National State…